Task: Answer Verification
Input (English): Question: Is dNA methylation of CHFR a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer?
Answer: We conclude that the DNA methylation of CHFR alone cannot predict the response of advanced and recurrent GC to docetaxel or paclitaxel. Both paclitaxel and docetaxel may be effective for treatment of GC even if CHFR is expressed.
Output (English): no